Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

Tofacitinib helped some young children with severe hair loss grow their hair back without bad side effects.

Tofacitinib may help treat severe childhood alopecia areata, but risks require careful consideration.

Higher BMI links to worse hair loss in Taiwanese men.

Some treatments like intralesional steroids and 5α-reductase inhibitors are effective for frontal fibrosing alopecia, but more research is needed.

Loss of sebaceous glands and inflammation may contribute to the development of scarring alopecia.

Dermoscopy is useful for diagnosing various skin, hair, and nail disorders and can reduce the need for biopsies.

People with hair loss have higher risk of high blood sugar and diabetes, and lower levels of a specific hormone.

Finasteride significantly improves hair growth but may cause sexual side effects.

Hormone treatments can help with women's skin and hair disorders, but they need careful monitoring and more research.

Vertex pattern hair loss linked to higher prostate cancer risk.

Pioglitazone usually doesn't effectively treat or cure lichen planopilaris.

FPHL common in Taiwanese women; risk factors include BMI, high glucose, early puberty, fewer childbirths, oral contraceptives, and UV exposure.

Prostaglandin F2α analogs show promise for treating certain types of hair loss but need more research for other skin conditions.

Loose anagen hair syndrome is caused by structural abnormalities in the hair follicle's inner root sheath.

New criteria for diagnosing frontal fibrosing alopecia include specific scalp and eyebrow hair loss as major factors and other hair loss areas and hair analysis as minor factors.

A team approach is crucial for managing PCOS, with dermatologists playing a key role.

The conclusion suggests a possible link between iron levels and hair health in women, recommending further research on iron supplementation for hair loss.

Bimatoprost is safe but not effective for severe eyelash loss from alopecia areata, possibly helping those with less loss.

Early hair loss may indicate prostate issues.

Patients with rapidly progressive alopecia areata often have a better outlook and shorter disease duration, with regrown fine hairs and no past alopecia being positive signs.

Using 2% tofacitinib cream with narrowband ultraviolet B improved facial vitiligo by 70% in patients who didn't respond to previous treatments, with no side effects reported.

Erosive pustular dermatosis of the scalp is a type of skin inflammation often confused with other conditions, requiring continuous treatment.

Genes linked to fibrosis are more active in people with central centrifugal cicatricial alopecia.

Two transplant patients on cyclosporine unexpectedly developed hair loss.

The review highlights the need for more research on transgender dermatology, the role of dermatologists in gender affirmation, and the effects of hormone therapy on skin and hair.

Topical DPCP is somewhat effective for hair loss in alopecia areata, but more research is needed.

Vemurafenib therapy can cause hair loss, but clobetasol propionate foam can help regrow hair.

CD3+ T-cell presence is a reliable marker to tell apart alopecia areata from pattern hair loss.

Using systemic drugs as creams for skin conditions shows promise, but more research is needed to confirm their effectiveness and safety.